Atara Biotherapeutics, Inc. (ATRA) vs Cibus, Inc. (CBUS)
- Atara Biotherapeutics, Inc. ATRA 9.18 −4.87%
- Cibus, Inc. CBUS 1.32 +2.33%
Atara Biotherapeutics, Inc. and Cibus, Inc. are both Biotechnology companies. Atara Biotherapeutics, Inc. and Cibus, Inc. are of similar size ($98.6M and $96.9M). Cibus, Inc. grew revenue faster over the last twelve months: −10.3% against −96.7%. Atara Biotherapeutics, Inc. has the higher net margin (−269.4% vs −2,258.9%) and the higher return on invested capital (0.00% vs 0.00%). Across the 15 metrics below, Atara Biotherapeutics, Inc. leads on 10 and Cibus, Inc. on 5.
Valuation
Profitability
| Metric | ATRA | CBUS | Biotechnology median |
|---|---|---|---|
| Gross margin | 91.38% | 100.00% | 65.16% |
| Operating margin | (229.67%) | (1,450.59%) | 0.00% |
| Net margin | (269.42%) | (2,258.89%) | 0.00% |
| Free cash flow margin | (353.49%) | (1,064.60%) | 0.00% |
| Return on equity | 46.33% | (219.97%) | (56.36%) |
| Return on assets | (57.62%) | (29.77%) | (48.04%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack